Start-up working on breakthrough in 3-D printing of human organs


A recent article on Prellis Biologics raising $1.8 million in new seed funding – 

Prellis Biologics, a human tissue engineering company, has invented a new way to create what it says are viable human organs using near instantaneous 3-D printing. This type of development, if proven out, could be a boon for hospitals and health systems with long lists of patients waiting for donor organs.

Founded by two scientists with extensive experience in 3-D tissue imaging and stem cell biology, Prellis Biologics says it is solving the greatest obstacle to producing functional human tissue in the lab – the ability to print microvasculature. Without the complex microvascular system needed to supply nutrients and oxygen to cells, an organ cannot survive.

True Ventures, a Silicon Valley venture capital firm specializing in early-stage technology start-ups, just led a $1.8 million seed investment in Prellis Biologics. Civilization Ventures and 415 Ventures also joined, along with angel investors. This round follows early support by IndieBio, an accelerator for biotech startups run by SOSV. Investment in the 10-month-old company totals $1.92 million.

Read the full article